EDGAR Filing Documents for 0001140361-09-010995

Form 8-K - Current report:

SEC Accession No. 0001140361-09-010995

Filing Date

2009-05-05

Accepted

2009-05-05 06:05:53

Documents

Period of Report

2009-05-04

Items

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	REXAHN PHARMACEUTICALS 8-K 5-4-2009	form8k.htm	8-K	28702
2	EXHIBIT 99.1	ex99_1.htm	EX-99.1	10984
	Complete submission text file	0001140361-09-010995.txt		41365

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850

Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300

REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)